Pegylated interferon-alpha plus taurine in treatment of rat liver fibrosis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 23

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

408

HTML

3414

Figures (1-3)

271

Tables (1-2)

212

Sum=4305

Jun 21, 2007 (publication date) through Feb 18, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jun 21, 2007; 13(23): 3237-3244
Published online Jun 21, 2007. doi: 10.3748/wjg.v13.i23.3237

Table 1 Histological scoring model

0	No fibrosis or minimal fibrous expansion of occasional portal areas
1	Moderate fibrous expansion of some portal areas with short fibrous septae
2	Moderate fibrous expansion of most portal areas, occasional portal-to-portal bridging
3	None or minimal expansion of portal areas, porto-portal fibrosis, incomplete bridging nodules
4	Marked portal fibrosis, portal to portal fibrosis, occasional micronodules
5	Mild to moderate fibrous expansion in portal areas, micronodules, incomplete cirrhosis
6	Marked fibrosis in portal areas, macro- and micronodules with thick fibrous septae, complete cirrhosis

Citation: Tasci I, Mas MR, Vural SA, Deveci S, Comert B, Alcigir G, Mas N, Akay C, Bozdayi M, Yurdaydin C, Bozkaya H, Uzunalimoglu O, Isik AT, Said HM. Pegylated interferon-alpha plus taurine in treatment of rat liver fibrosis. World J Gastroenterol 2007; 13(23): 3237-3244
URL: https://www.wjgnet.com/1007-9327/full/v13/i23/3237.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i23.3237